Gebot Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 22 Year, 11 Months
- Last Filing with ROC 31 Mar 2016
- Open Charges ₹ 0.50 M
- Revenue Growth -13.60%
- Profit Growth -202.56%
- Ebitda -130.84%
- Net Worth -27.41%
- Total Assets 2.67%
About Gebot Biotech
Gebot Biotech Private Limited (GBPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 March 2002 and has a history of 22 years and 11 months. Its registered office is in Bhopal, Madhya Pradesh, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2016. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹0.50 M.
Saroj Gupta, Madhu Kalwani, and Santosh Motwani serve as directors at the Company.
Company Details
- Location
Bhopal, Madhya Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24232MP2002PTC015019
- Company No.
015019
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Mar 2002
- Date of AGM
15 Sep 2016
- Date of Balance Sheet
31 Mar 2016
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Gebot Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Santosh Motwani  | Additional Director | 17-Mar-2017 | Current |
| Saroj Gupta | Director | 09-Aug-2002 | Current |
| Madhu Kalwani | Additional Director | 17-Mar-2017 | Current |
Financial Performance of Gebot Biotech.
Gebot Biotech Private Limited, for the financial year ended 2016, experienced significant reduction in revenue, with a 13.6% decrease. The company also saw a substantial fall in profitability, with a 202.56% decrease in profit. The company's net worth observed a substantial decline by a decrease of 27.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gebot Biotech?
In 2016, Gebot Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ayushman Hospital And Research Centre Pvt LtdSaroj Gupta is a mutual person
Charges (Loans)
₹0.50 M
₹0
Charges Breakdown by Lending Institutions
- Punjab National Bank : 0.05 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Aug 2007 | Punjab National Bank | ₹0.50 M | Open |
How Many Employees Work at Gebot Biotech?
Unlock and access historical data on people associated with Gebot Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gebot Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gebot Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
